Edesa Biotech, Inc. (EDSA)
NASDAQ: EDSA · Real-Time Price · USD
1.090
-0.050 (-4.39%)
At close: Feb 4, 2026, 4:00 PM EST
1.100
+0.010 (0.92%)
After-hours: Feb 4, 2026, 6:34 PM EST
Edesa Biotech Market Cap
Edesa Biotech has a market cap or net worth of $9.08 million as of February 4, 2026. Its market cap has increased by 54.08% in one year.
Market Cap
9.08M
Enterprise Value
-1.71M
1-Year Change
54.08%
Ranking
Category
Stock Price
$1.09
Market Cap Chart
Since June 10, 2019, Edesa Biotech's market cap has decreased from $37.12M to $9.08M, a decrease of -75.53%. That is a compound annual growth rate of -19.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 3, 2026 | 9.50M | -19.72% |
| Dec 31, 2025 | 11.83M | 103.14% |
| Dec 31, 2024 | 5.83M | -59.72% |
| Dec 29, 2023 | 14.46M | -65.40% |
| Dec 30, 2022 | 41.80M | -45.08% |
| Dec 31, 2021 | 76.11M | 70.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 10, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sensei Biotherapeutics | 11.35M |
| Akari Therapeutics, | 11.06M |
| Imunon | 11.03M |
| NuCana | 10.82M |
| GridAI Technologies | 10.66M |
| Phio Pharmaceuticals | 10.64M |
| BioAtla | 10.54M |
| Chemomab Therapeutics | 10.22M |